• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

C反应蛋白可预测血液透析患者的全因死亡率和心血管死亡率。

C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients.

作者信息

Yeun J Y, Levine R A, Mantadilok V, Kaysen G A

机构信息

Department of Medicine, Division of Nephrology, and the Department of Statistics, University of California Davis, Sacramento 95817, USA.

出版信息

Am J Kidney Dis. 2000 Mar;35(3):469-76. doi: 10.1016/s0272-6386(00)70200-9.

DOI:10.1016/s0272-6386(00)70200-9
PMID:10692273
Abstract

Hypoalbuminemia predicts death in dialysis patients. Although hypoalbuminemia has been attributed to malnutrition, evidence of inflammation (C-reactive protein [CRP] and cytokine levels) has recently been recognized to predict albumin concentration in dialysis patients. We measured CRP and albumin levels in October 1995 in 91 hemodialysis (HD) patients. During a 34-month follow-up period, we determined the incidence and cause of death. Patients were divided into four groups based on serum albumin levels (<3.5 [lowest quartile], 3.5 to 3.8, 3.9 to 4.0, and >4.0 g/dL [highest quartile]). Survival differed among the four groups (P = 0.0063). Patients with albumin levels greater than 4.0 g/dL had the greatest survival. Kaplan-Meier survival estimates of patients from varying CRP quartiles (<2.6, 2.6 to 5.2, 5.3 to 11.5, and >11.5 microg/mL) differed among the four groups (P < 0.0001). The group with the greatest CRP level (>11.5 microg/mL) had the lowest survival. Multivariate analysis using the Cox proportional hazards model showed that only CRP level (chi-square = 21.11; P < 0.0001) and age (chi-square = 5.44; P = 0.020) predicted death. Albumin level (chi-square = 0.16; P = 0.69) was not predictive. Only when CRP was excluded from the model did low serum albumin level (chi-square = 12. 04; P = 0.0004) predict death. CRP level (chi-square = 16.79; P < 0. 0001) and age (chi-square = 6.38; P = 0.012) also superceded albumin level (chi-square = 0.45; P = 0.51) in predicting cardiovascular mortality. Although values for blood urea nitrogen, creatinine, and normalized protein catabolic rate were significantly less among patients who died, these parameters, as well as cholesterol level and diabetes, were not important predictors of death in multivariate analysis. The acute-phase response or the cause of the acute-phase response is largely responsible for the effect of hypoalbuminemia on mortality in HD patients.

摘要

低白蛋白血症可预测透析患者的死亡。尽管低白蛋白血症一直被归因于营养不良,但炎症证据(C反应蛋白[CRP]和细胞因子水平)最近已被认为可预测透析患者的白蛋白浓度。我们于1995年10月测量了91例血液透析(HD)患者的CRP和白蛋白水平。在34个月的随访期内,我们确定了死亡的发生率和原因。根据血清白蛋白水平(<3.5[最低四分位数]、3.5至3.8、3.9至4.0以及>4.0 g/dL[最高四分位数])将患者分为四组。四组患者的生存率存在差异(P = 0.0063)。白蛋白水平大于4.0 g/dL的患者生存率最高。不同CRP四分位数(<2.6、2.6至5.2、5.3至11.5以及>11.5 μg/mL)患者的Kaplan-Meier生存估计在四组间存在差异(P < 0.0001)。CRP水平最高(>11.5 μg/mL)的组生存率最低。使用Cox比例风险模型进行的多变量分析显示,只有CRP水平(卡方 = 21.11;P < 0.0001)和年龄(卡方 = 5.44;P = 0.020)可预测死亡。白蛋白水平(卡方 = 0.16;P = 0.69)无预测作用。只有当CRP被排除在模型之外时,低血清白蛋白水平(卡方 = 12.04;P = 0.0004)才可预测死亡。在预测心血管死亡率方面,CRP水平(卡方 = 16.79;P < 0.0001)和年龄(卡方 = 6.38;P = 0.012)也超过了白蛋白水平(卡方 = 0.45;P = 0.51)。尽管死亡患者的血尿素氮、肌酐和标准化蛋白分解率值显著较低,但在多变量分析中,这些参数以及胆固醇水平和糖尿病并非死亡的重要预测因素。急性期反应或急性期反应的原因在很大程度上导致了低白蛋白血症对HD患者死亡率的影响。

相似文献

1
C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients.C反应蛋白可预测血液透析患者的全因死亡率和心血管死亡率。
Am J Kidney Dis. 2000 Mar;35(3):469-76. doi: 10.1016/s0272-6386(00)70200-9.
2
Inflammation predicts all-cause and cardiovascular mortality in haemodialysis patients.炎症可预测血液透析患者的全因死亡率和心血管死亡率。
Prilozi. 2006 Jul;27(1):133-44.
3
[Nutritional status, comorbidity, and inflammation in hemodialysis].[血液透析中的营养状况、合并症和炎症]
Nefrologia. 2000 Nov-Dec;20(6):540-9.
4
Inflammation and malnutrition as predictors of mortality in patients on hemodialysis.炎症和营养不良作为血液透析患者死亡率的预测因素。
J Nephrol. 2002 Mar-Apr;15(2):136-43.
5
Longitudinal and cross-sectional effects of C-reactive protein, equilibrated normalized protein catabolic rate, and serum bicarbonate on creatinine and albumin levels in dialysis patients.C反应蛋白、平衡标准化蛋白质分解代谢率和血清碳酸氢盐对透析患者肌酐和白蛋白水平的纵向及横断面影响。
Am J Kidney Dis. 2003 Dec;42(6):1200-11. doi: 10.1053/j.ajkd.2003.08.021.
6
Significance of albumin and C-reactive protein variations in 300 end stage renal disease patients in Tehran University of Medical Sciences Hospitals during year 2010.2010年德黑兰医科大学附属医院300例终末期肾病患者白蛋白和C反应蛋白变化的意义
Acta Med Iran. 2012;50(3):197-202.
7
Inflammation enhances cardiovascular risk and mortality in hemodialysis patients.炎症会增加血液透析患者的心血管风险及死亡率。
Kidney Int. 1999 Feb;55(2):648-58. doi: 10.1046/j.1523-1755.1999.00273.x.
8
Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.血清白蛋白、C反应蛋白、白细胞介素6和胎球蛋白A作为终末期肾病患者营养不良、心血管疾病及死亡率的预测指标。
Am J Kidney Dis. 2006 Jan;47(1):139-48. doi: 10.1053/j.ajkd.2005.09.014.
9
Both low and high serum ferritin levels predict mortality risk in hemodialysis patients without inflammation.血清铁蛋白水平过低和过高均预示着无炎症的血液透析患者的死亡风险。
Clin Exp Nephrol. 2017 Aug;21(4):685-693. doi: 10.1007/s10157-016-1317-1. Epub 2016 Aug 8.
10
Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients.炎症、营养不良和心脏病作为血液透析患者死亡率的预测因素。
J Am Soc Nephrol. 2002 Jan;13 Suppl 1:S28-36.

引用本文的文献

1
Does Control Nutritional Status (CONUT) Score Predict Early and Long-Term Mortality at the Initiation of Maintenance Hemodialysis?控制营养状况(CONUT)评分能否预测维持性血液透析开始时的早期和长期死亡率?
Int J Gen Med. 2025 Jul 7;18:3775-3786. doi: 10.2147/IJGM.S533080. eCollection 2025.
2
ENDOCRINE AND GROWTH ABNORMALITIES IN CHILDREN WITH KIDNEY FAILURE ON MAINTENANCE HEMODIALYSIS - EXPERIENCE OF A SINGLE CENTER FROM WESTERN ROMANIA.维持性血液透析的肾衰竭儿童的内分泌与生长异常——罗马尼亚西部单中心经验
Acta Endocrinol (Buchar). 2024 Jul-Sep;20(3):393-400. doi: 10.4183/aeb.2024.393. Epub 2025 May 23.
3
Effects of anti-inflammatory agents on clinical outcomes in people with chronic kidney disease: a systematic review and meta-analysis of randomized control trials.
抗炎药物对慢性肾脏病患者临床结局的影响:一项随机对照试验的系统评价和荟萃分析
Clin Kidney J. 2025 Jan 14;18(3):sfaf001. doi: 10.1093/ckj/sfaf001. eCollection 2025 Mar.
4
A meta-analysis of the impact of initial hemodialysis access type on mortality in elderly incident hemodialysis population.初始血液透析通路类型对老年初治血液透析人群死亡率影响的荟萃分析。
BMC Geriatr. 2025 Mar 19;25(1):186. doi: 10.1186/s12877-025-05696-0.
5
The Role of Zinc Supplementation in Alleviating Inflammatory Biomarkers in Patients Undergoing Hemodialysis: A Randomized Placebo Controlled, Crossover Trial.补充锌对减轻血液透析患者炎症生物标志物的作用:一项随机安慰剂对照交叉试验。
Iran J Pharm Res. 2024 Sep 15;23(1):e147887. doi: 10.5812/ijpr-147887. eCollection 2024 Jan-Dec.
6
Prognostic potential of inflammatory markers in chronic kidney disease patients combined with acute myocardial infarction.炎症标志物在慢性肾脏病合并急性心肌梗死患者中的预后潜力
Front Cardiovasc Med. 2024 Dec 19;11:1430215. doi: 10.3389/fcvm.2024.1430215. eCollection 2024.
7
Unique Pathological Findings of Polarized Calcium Oxalate Crystals in Spondylodiscitis of an ESRD Hemodialysis Patient: A Case Report.终末期肾病血液透析患者脊椎椎间盘炎中极化草酸钙晶体的独特病理发现:一例报告
Clin Case Rep. 2024 Dec 6;12(12):e9709. doi: 10.1002/ccr3.9709. eCollection 2024 Dec.
8
Evaluation of Inflammatory Status in Chronic Kidney Disease Patients and a Comparison Between Hemodialysis and Peritoneal Dialysis Patients.慢性肾脏病患者炎症状态的评估及血液透析与腹膜透析患者的比较
Cureus. 2024 Sep 15;16(9):e69443. doi: 10.7759/cureus.69443. eCollection 2024 Sep.
9
The Controversies of Coronary Artery Disease in End-Stage Kidney Disease Patients: A Narrative Review.终末期肾病患者冠状动脉疾病的争议:一项叙述性综述
Rev Cardiovasc Med. 2023 Jun 25;24(6):181. doi: 10.31083/j.rcm2406181. eCollection 2023 Jun.
10
The predictive value of cardiovascular outcomes and mortality assessed by the C-reactive protein to albumin ratio in the UK Biobank.英国生物库中 C 反应蛋白与白蛋白比值评估的心血管结局和死亡率的预测价值。
BMC Cardiovasc Disord. 2024 Jun 26;24(1):326. doi: 10.1186/s12872-024-03995-9.